INNT
TOTAL INVALIDATION PROCESSED BY THE IB
02/19/2026
Back to search
Official data from USPTO
TASLY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
02/20/2026
Trademark type
Combined
Nice classes
5
Filing date
11/10/2016
Registration date
05/29/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/13/2024
Last transaction
02/20/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CN
Examiner
STRUCK, ROBERT J
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of an outline of a shaded triangle with two cut-outs in the shape of horizontal bars crossing through the top half; a smaller shaded triangle appears inside. To the right of the triangles appears the literal element "TASLY".
Holders and representatives
Holders
Tasly Pharmaceutical Group Co., Ltd.
Representatives
Michael D. Schumann Hamre, Schumann, Mueller & Larson, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicine for human purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Chemico-pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Raw material medicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Biomedicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; pharmaceutical herbs for medical purposes; Prepared Chinese medicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Capsules for medicinescapsules sold empty for pharmaceuticals; Pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Dietetic food and beverages adapted for medical use; bath preparationsmedicated; Medical analgesic preparations; preparations for the treatment of burns; Syrups for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; vitamin preparations; sunburn preparations for pharmaceutical purposes; vaccines; detergents for medical purposes; disinfectants for hygiene purposes; digestives for pharmaceutical purposes; mineral water for medical purposes; Mineral salts for medical purposes; purgatives; meal for pharmaceutical purposes; flour for pharmaceutical purposes; febrifuges; medicinal tea; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; anthelmintics; Pharmaceutical Gelatingelatin capsules sold empty for pharmaceuticals ; germicides; greases for medical purposes; chemical preparations for the diagnosis of pregnancy; medicinal oils; medicinal herbs; Lotions for pharmaceutical purposesanti-bacteria hand washing solutionoral washingsgynecological washingsanorectal washings; Ointments for pharmaceutical purposessunburn ointmentsanti-inflammatory ointmentshemorrhoidal ointmentsfrostbite salve for pharmaceutical purposeseye ointments; Pectin for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; herbs teas for medicinal purposes; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; first-aid boxesfilled; medicinal roots; medicinal herbal preparationstonics medicine; sedatives; soporifics; sugar for medical purposes; Biological preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; medical preparations for slimming purposes; by-products of the processing of cereals for dietetic or medical purposes; medicines for dental purposes; Diagnostic preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; medicinal drinks; ferments for pharmaceutical purposes; chemical reagents for medical or veterinary purposes; Dietary fiber to aid digestion; enzyme preparations for medical purposes; amino acids for pharmaceutical purposes; mouthwashes for medical purposes; appetite suppressants for medical purposes; adjuvants for medical purposes; Weight-reducing aidweight management supplements; Medicine for the treatment of sunburns; Food supplementsantioxidants used for medicinal purposes; acne treatment preparation; Medicinal herbal preparationslysine electuary; oral rehydration salts; Medicinal liquor for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Medicinal herbal preparationsginseng electuary; Ginseng for medicinal use; Medicinal herbal preparationsmedlar; Dietetic beverages adapted for medicinal purposesweight-reducing tea; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; nutritional food additives for medical purposes in the nature of natural food extracts derived from fishmeatvegetablesfruits; food for babies; milk powder for infants; air purifying preparations; Medicated animal washes; Veterinary preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Medicated animal feed; biocides; vermin destroying preparations; sanitary towels; wadding for medical purposes; medical dressings; rubber for dental purposes; teeth filling material; diaper for pets
Publications
History of USPTO decisions and trademark events.
35 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/01/2026
INPC
INVALIDATION PROCESSED
02/01/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/13/2025
C71T
CANCELLED SECTION 71
12/13/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/29/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/29/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/11/2018
FIMP
FINAL DISPOSITION PROCESSED
09/11/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/29/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/29/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/13/2018
PUBO
PUBLISHED FOR OPPOSITION
03/13/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/21/2018
RFNT
REFUSAL PROCESSED BY IB
02/10/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/21/2017
GNRT
NON-FINAL ACTION E-MAILED
12/21/2017
CNRT
NON-FINAL ACTION WRITTEN
12/21/2017
DOCK
ASSIGNED TO EXAMINER
12/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/21/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/20/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/20/2017
RFNT
REFUSAL PROCESSED BY IB
09/22/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/01/2017
RFRR
REFUSAL PROCESSED BY MPU
09/01/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/30/2017
CNRT
NON-FINAL ACTION WRITTEN
08/29/2017
MAFR
APPLICATION FILING RECEIPT MAILED
08/25/2017
DOCK
ASSIGNED TO EXAMINER
08/21/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/21/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/17/2017
Continuous trademark protection
Get notified about every new filing that threatens TASLY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.